Fresenius Medical Care Ag (FMS) Return on Assets ROA from the fourth quarter of 2025 to fourth quarter of 2024 and for the year 2025, Average High and Low, Fundamental Ratios from Dec 31 2025 to Dec 31 2024 - CSIMarket
CSIMarket
 


Fresenius Medical Care Ag  (NYSE: FMS)
    Sector  Healthcare    Industry Healthcare Facilities
   Industry Healthcare Facilities
   Sector  Healthcare


Fresenius Medical Care Ag's ROA from the fourth quarter of 2025 to the fourth quarter of 2024 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Fresenius Medical Care Ag's ROA in the fourth quarter of 2025?
Fresenius Medical Care Ag achieved a return on average assets (ROA) of 3.88 % in its fourth quarter of 2025, which is below Fresenius Medical Care Ag's average return on assets, which stands at 4.58%.

ROA has improved compared to 2.86% in the third quarter of 2025, due to net income growth.

However, within the Healthcare sector 166 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the third quarter of 2025 from to 2083.

What is ROA?



Return On Assets (Dec 31 2025)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter
(Dec 31 2024)
IV. Quarter
Y / Y Total Assets Change -7.64 % -7.64 % -8.8 % -7.64 % -1.07 %
Y / Y Net Income Change 266.77 % 31.88 % 19.3 % 55.47 % -55.02 %
Net Income (TTM) in million 1,347 1,015 923 873 802
Return On Assets (TTM) 3.88 % 2.86 % 2.55 % 2.36 % 2.13 %
FMS's Total Ranking # 2083 # # # # 2170
Total Assets (TTM) in million 34,723 34,723 34,723 34,723 37,595
Seq. Total Assets Change 0 % 0 % 0 % -7.64 % 0 %
Seq. Net Income Change 19.17 % 23.86 % 54.66 % 60.66 % -57.15 %



Return On Assets Company Ranking
Within: No.
Industry # 23
Sector # 167
Overall # 1633

Return On Assets Statistics
High Average Low
7.4 %
4.58 %
2.16 %
(Dec 31 2018)   (Dec 31 2023)





Financial Statements
Fresenius Medical Care Ag's Assets $ 34,723 million FMS's Balance sheet
Fresenius Medical Care Ag's Income $ 456 million Quarterly FMS's Income Statement
FMS's Income by Division See FMS's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025
(Dec 31 2024)
FY 2024
(Dec 31 2023)
FY 2023
(Dec 31 2022)
FY 2022
(Dec 31 2021)
FY 2021
Y / Y Total Assets Change -7.64 % -1.07 % -5.1 % 4.04 % 8.45 %
Total Assets in million 34,723 37,595 38,001 40,045 38,491
Y / Y Net Income Change 60.79 % 1.15 % -18.1 % -26.64 % -15.1 %
Net Income in million 1,334 830 820 1,002 1,365
Annual Return On Assets 3.84 % 2.21 % 2.16 % 2.5 % 3.55 %




Comment on FMS's ROA in the fiscal year ending 2025
In the fiscal year 2025 ROA improved to 3.84 % compared to prior year, due to annual net income growth of 60.79 % to $1,334.22 million, and due to decline of value in Fresenius Medical Care Ag's assets by -7.64 % to $34,722.61 million, compared to $34,722.61 a year before.


More Return On Assets Ratios
FMS's' Return on Assets at Yahoo Finance
Healthcare Facilities Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
FMS's Roa Ratio versus Healthcare Facilities Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for FMS's Competitors
Subscribers only: Roa for Fresenius Medical Care Ag's Suppliers
Subscribers only: Return On Assets for FMS's Customers

You may also want to know
FMS's Roi FMS's Inventory Turnover Ratio FMS's Growth Rates FMS's Dividend Comparisons
FMS's Profitability Ratios FMS's Asset Turnover Ratio FMS's Dividend Growth
FMS's Roe FMS's Valuation Ratios FMS's Financial Strength Ratios FMS's Dividend Payout Ratio



Companies with similar Return On Assets at Dec 31 2025, within Healthcare Sector ROA
Ufp Technologies Inc   10.57 %
Alkermes Plc   10.56 %
Pacific Health Care Organization Inc  10.53 %
Penumbra Inc  10.39 %
Agilent Technologies inc   10.35 %
Gsk Plc  10.29 %
Ligand Pharmaceuticals Incorporated  10.18 %
Cryoport inc   10.09 %
Siga Technologies Inc  9.98 %
Universal Health Services Inc   9.95 %
Lemaitre Vascular Inc   9.84 %
Galapagos Nv  9.42 %
Nephros Inc   9.38 %
Utah Medical Products Inc  9.25 %
Vaxart Inc   9.10 %
Astrazeneca Plc  8.97 %
Kiniksa Pharmaceuticals International Plc  8.63 %
Amgen Inc   8.62 %
3m Company  8.51 %
Nrc Health  8.48 %
Cypherpunk Technologies Inc   8.40 %
Profound Medical Corp   8.29 %
Tenet Healthcare Corp  8.09 %
Viemed Healthcare Inc   8.05 %
Edwards Lifesciences Corporation  8.00 %
Nature s Sunshine Products inc   7.92 %
National Healthcare Corp  7.90 %
Abbott Laboratories  7.76 %
Pediatrix Medical Group Inc   7.74 %
Progyny Inc   7.73 %


Date modified: 2026-09-08T17:43:40+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.